Boston Medical Center, the Boston University School of Medicine, and the Boston University School of Social Work will establish the Clinical Addiction Research and Education (CARE) Program. Under the direction of Jeffrey Samet, M.D., an experienced NIDA researcher, and Maryann Amodeo, Ph.D., a recognized expert in drug abuse training, three major aims will be pursued: (1) Generalist physicians in Internal Medicine, Family Practice, or Emergency Medicine will be mentored and trained to develop into drug abuse researchers; (2) Chief residents will gain skills in assessment and treatment of drug-abusing patients in medical settings and incorporate these skills into resident and medical student teaching; and (3) Management and staff of community-based organizations (CBOs) providing drug treatment will undergo agency change efforts to incorporate evidenced-based approaches in their practice. The CARE Program's special character comes from a strong collaboration between medicine and social work and several other unique elements: (1) a prestigious Advisory Committee of regional and national experts providing oversight; (2) """"""""cross-fertilization"""""""" between program components ensuring that all participants learn about drug abuse research, clinical practice, and research-to-practice challenges; (3) activities focusing on the care of multiethnic, vulnerable populations; (4) NIDA-funded research projects serving as sites for the training of physician researchers; (5) four national medical associations facilitating recruitment of physicians; (6) key community CBOs committing themselves to the organizational change process; and (7) an experienced addiction evaluation team conducting the program evaluation. Long-term outcomes are engagement of generalist physicians to contribute to the research and clinical needs of drug-abusing patients, improved drug treatment CBO personnel skills resulting in better client outcomes, and closer links between the hospital, university, and CBOs for future collaborations.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Education Projects (R25)
Project #
5R25DA013582-04
Application #
6747844
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Flanzer, Jerry
Project Start
2001-05-01
Project End
2006-04-30
Budget Start
2004-05-01
Budget End
2005-04-30
Support Year
4
Fiscal Year
2004
Total Cost
$387,678
Indirect Cost
Name
Boston Medical Center
Department
Type
DUNS #
005492160
City
Boston
State
MA
Country
United States
Zip Code
02118
Weinstein, Zoe M; Gryczynski, Gabriela; Cheng, Debbie M et al. (2018) Tapering off and returning to buprenorphine maintenance in a primary care Office Based Addiction Treatment (OBAT) program. Drug Alcohol Depend 189:166-171
Alford, Daniel P; Carney, Brittany L; Jackson, Angela H et al. (2018) Promoting addiction medicine teaching through functional mentoring by co-training generalist chief residents with faculty mentors. Subst Abus :1-7
Barocas, Joshua A; White, Laura F; Wang, Jianing et al. (2018) Estimated Prevalence of Opioid Use Disorder in Massachusetts, 2011-2015: A Capture-Recapture Analysis. Am J Public Health 108:1675-1681
Hadland, Scott E; Bagley, Sarah M; Rodean, Jonathan et al. (2018) Receipt of Timely Addiction Treatment and Association of Early Medication Treatment With Retention in Care Among Youths With Opioid Use Disorder. JAMA Pediatr 172:1029-1037
Morgan, Jake R; Schackman, Bruce R; Leff, Jared A et al. (2018) Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population. J Subst Abuse Treat 85:90-96
Bagley, Sarah M; Cheng, Debbie M; Winter, Michael et al. (2018) Opioid and cocaine use among primary care patients on buprenorphine-Self-report and urine drug tests. Drug Alcohol Depend 192:245-249
Idrisov, Bulat; Lunze, Karsten; Cheng, Debbie M et al. (2017) Role of substance use in HIV care cascade outcomes among people who inject drugs in Russia. Addict Sci Clin Pract 12:30
Weinstein, Zoe M; Cheng, Debbie M; Quinn, Emily et al. (2017) Psychoactive medications and disengagement from office based opioid treatment (obot) with buprenorphine. Drug Alcohol Depend 170:9-16
Hui, David; Weinstein, Zoe M; Cheng, Debbie M et al. (2017) Very early disengagement and subsequent re-engagement in primary care Office Based Opioid Treatment (OBOT) with buprenorphine. J Subst Abuse Treat 79:12-19
Trowbridge, Paul; Weinstein, Zoe M; Kerensky, Todd et al. (2017) Addiction consultation services - Linking hospitalized patients to outpatient addiction treatment. J Subst Abuse Treat 79:1-5

Showing the most recent 10 out of 57 publications